Advanced Cell Line Development & Bioprocess Technology: From Clone Selection to Commercial Manufacturing Readiness
Ambrish Saxena
About Me
Dr. Saxena is an experienced biopharmaceutical professional with expertise in biologics, cell line development, viral vectors, and mRNA therapeutics. He has held leadership roles at Pfizer, Sun Pharma, Syngene, and Lonza, leading scientific teams and biologics development programs. He is currently a Visiting Faculty at IIT Tirupati and holds a Ph.D. in Biochemistry and Molecular Biology, along with postgraduate qualifications in Intellectual Property Law.Courses by me
Cell Line Development, Clone Selection, Bioprocess Optimisation, Upstream Processing, Downstream Purification, CPPs, CQAs, Process Characterisation, Scale-Up, Technology Transfer
Viral Vectors, mRNA Therapeutics, Advanced Biologics, CMC, Process Development, Manufacturing Strategy, Regulatory Strategy, Platform Selection
Evaluate biologics and advanced-therapy technology platforms, assess market opportunities and competitive positioning, understand manufacturing and commercialisation challenges, and build technology and business strategy frameworks.
Translate pharma R&D data into actionable insights, apply descriptive, diagnostic and predictive analytics, define R&D KPIs, design stakeholder-focused dashboards, identify performance drivers and communicate evidence-based recommendations.
Identify AI/ML applications across biologics R&D, apply Generative AI for scientific research and documentation, convert experimental data into actionable insights, evaluate AI outputs for scientific reliability, and build AI-enabled R&D decision frameworks.